Abstract:BACKGROUND:To improve the targeting ability of antitumor drugs, we identified the antigens with high expression on the surface of tumor cells associated with tumor escape, such as the complement regulatory protein CD55 molecule, which is also known as the decay accelerating factor. In this study, phage display technology was used to screen and identify CD55-specific ligand peptide (CD55sp) bound to CD55 molecule on the surface of cervical cancer HeLa cells. We then explored the role of this peptide in inhibiting the growth of cervical cancer cells in vitro. Our characterization of CD55sp will provide implication for tumor target therapy.METHODS:The phage bound to the surface of HeLa cells were isolated by phage display technology. Positive phage clones were identified by ELISA. Phage was then amplified and determined by agarose gel electrophoresis after monoclonal DNA extraction. DNA sequencing and bioinformatical analysis were conducted to obtain specific ligand peptides. Flow cytometry and immunofluorescence were used to measure the expression of CD55 molecule on the surface of tumor and normal cells. Subsequently, the effects of CD55sp on the proliferation and apoptosis of HeLa and SiHa cells were determined by Cell Counting Kit-8 (CCK-8), flow cytometry, and TUNEL assay, respectively. The morphology of apoptotic cells was examined by electron microscope. The distribution of Cleaved caspase-3 was detected by immunofluorescence. The expression of bcl-2 and Cleaved caspase-3 were determined by Western blot.RESULTS:The results showed that the peptide (QVNGLGERSQQM) can bind to the CD55 molecule on the surface of cervical cancer HeLa and SiHa cells as a ligand peptide. It can also effectively inhibit the proliferation of cervical cancer cells and induce cell apoptosis.CONCLUSION:This study demonstrates that CD55sp screened by phage display technology plays a strong antitumor role.

Specific coalescent peptides binding with CD59 on HeLa cells screened by phage peptide library

Screening and Identification of A Targeting Peptide to Nglp-1r from Phage Display Peptide Library

A Study on Screening and Antitumor Effect of CD55-specific Ligand Peptide in Cervical Cancer Cells.

Screening and identification of a specific peptide binding to cervical cancer cells from a phage-displayed peptide library

Rapid Identification Of Specific Dna Aptamers Precisely Targeting Cd33 Positive Leukemia Cells Through A Paired Cell-Based Approach

Specific Ligands for Classical Swine Fever Virus Screened from Landscape Phage Display Library.

Virus-Derived Peptides for Clinical Applications

Identification of a peptide binding to cancer antigen Kita‐kyushu lung cancer antigen 1 from a phage‐display library

Selection of Human Stem Cell Factor Mimetic Peptides from Phage-Displayed Random Peptide Library

Study of the Cyclic Peptide Binding to HIV-1 Gp41 NHR

Screening and identification of a specific peptide binding to breast cancer cells from a phage-displayed peptide library

Isolation and Identification of Specific Single Chain Antibodies Against Cell Surface Molecules

Recognition of cell surface proteins by high-density phage antibody chip

Rapid selection and identification of functional CD8+ T cell epitopes from large peptide-coding libraries

Construction and Screening of an Antigen-Derived Peptide Library Displayed on Yeast Cell Surface for CD4+ T Cell Epitope Identification

Identification of a Novel Peptide Ligand of Human Transfrrin Receptor 1 for Targeted Tumor Delivery Drug

The study of SLE associated peptide by phage-display random 15 amino acid peptide library

Identification of host cell binding peptide from an overlapping peptide library for inhibition of classical swine fever virus infection

[Screening of Breast Cancer Antigen from a Phage Display Random Peptide Library].

Inhibition Mechanism Research about CD59 Specific Site Closed Short Peptide on T Cell Leukemia

Phage Display Screening of Anchor Peptides for Red Blood Cell-Derived Extracellular Vesicles